Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
139 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Not yet recruiting Trial of Letrozole +/- Palbociclib in Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Palbociclib;   Drug: Letrozole
22 Not yet recruiting Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Nintedanib or Placebo; Carboplatin, Paclitaxel
23 Recruiting Enzalutamide in Combination With Carboplatin and Paclitaxel in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Enzalutamide;   Drug: Carboplatin;   Drug: Paclitaxel
24 Recruiting Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer
Conditions: Obese;   Endometrial Cancer
Intervention: Other: Perioperative Caloric Restriction Program
25 Recruiting Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation
Condition: Endometrial Cancer
Intervention: Procedure: Lymphadenectomy
26 Recruiting Advanced Methods for Cancer Detection by Vaginal Screening
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Other: Vaginal DNA Collection
27 Recruiting Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
Condition: Endometrial Cancer
Intervention: Drug: Lymphoseek plus Vital Blue Dye
28 Not yet recruiting Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)
Condition: Endometrial Cancer
Interventions: Procedure: Abdominal surgery;   Procedure: Lymphadenectomy
29 Recruiting Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients
Condition: Endometrial Cancer
Interventions: Device: ultrasound;   Other: blood test
30 Recruiting Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
Conditions: Endometrial Cancer;   Recurrent Endometrial Cancer
Intervention: Drug: LY3023414
31 Recruiting Use of the Sentinel Node Biopsy for Early Endometrial Cancer.
Condition: Cancer of Endometrium
Intervention: Procedure: Sentinel Lymph Node Biopsy
32 Recruiting Biomarker Guided Treatment in Gynaecological Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Biomarker (ER/PR) guided lymphadenectomy;   Drug: Biomarker guided weekly taxane treatment in endometrial/ ovarian cancer
33 Recruiting Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors
Conditions: Obesity;   Endometrial Carcinoma
Interventions: Procedure: Gentle yoga therapy;   Other: counseling intervention;   Other: educational intervention;   Other: quality-of-life assessment;   Other: questionnaire administration
34 Not yet recruiting ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?
Condition: Endometrial Cancer
Intervention: Other: Reduced follow-up schedule
35 Recruiting Phase II Study of Intrauterine Device (IUD) Alone or in Combination With Everolimus in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Device: Levonorgestrel Intrauterine Device (LIUD);   Drug: Everolimus;   Behavioral: Questionnaire
36 Recruiting Exercise as an Intervention in Endometrial Cancer Survivors
Conditions: Endometrial Cancer;   Quality of Life
Intervention: Behavioral: Exercise
37 Recruiting Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Selinexor
38 Recruiting A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
Condition: Endometrial Cancer
Intervention: Drug: Fluorescein
39 Recruiting Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer
Conditions: Endometrial Cancer;   Sentinel Lymph Node;   Indocyanine Green
Intervention: Biological: Indocyanine Green (ICG)
40 Recruiting Follow-up of Endometrial Cancer Patients
Condition: Endometrial Cancer
Intervention: Other: Instruction in self-referral

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.